AN2 Therapeutics, Inc. ($ANTX)
Filing Information
| Accession Number | 0001193125-26-420641 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 13, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
389
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Oct 12, 2026 | Grant/Award | 389 | $0.00 | $0.00 | 19,252 | Direct | โ | View Details |